Osteosarcoma: Individualized Precision Treatment and Effective Drug Discovery
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Drug Development".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 209
Special Issue Editor
Interests: osteosarcoma; bone cancer; tumor microenvironment; tumor acidosis; lipid metabolism; targeted therapies; precision medicine; microfluidics; 3D tumor models
Special Issue Information
Dear Colleagues,
Osteosarcoma is a highly aggressive cancer of mesenchymal origin that develops in bone. Despite decades of research, the survival rates for patients with osteosarcoma have remained largely unchanged. While surgery and conventional therapies remain the cornerstone of treatment, they offer limited benefits for patients with metastatic disease. This underscores the urgent need for innovative therapies to improve survival rates and reduce metastatic spread.
This Special Issue seeks to explore the latest advancements and future directions in understanding the molecular mechanisms underlying bone and soft tissue sarcomas. By delving into the molecular landscape of these tumors, we aim to highlight novel therapeutic strategies and their potential to transform the treatment of these challenging diseases.
Recent years have witnessed remarkable progress in targeted therapies and drug discovery for osteosarcoma. Advances in the molecular characterization of the disease have unveiled promising new targets and treatment avenues.
In this Special Issue, we bring together cutting-edge research and insights to summarize recent breakthroughs in precision medicine and innovative drug discovery for osteosarcoma, offering hope for improved patient outcomes and a brighter future in the fight against this formidable malignancy.
Dr. Margherita Cortini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- osteosarcoma
- bone cancer
- tumor microenvironment
- targeted therapies
- precision medicine
- 3D tumor models
- drug screening
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
